SJS Investment Consulting’s Boston Scientific BSX Stock Holding History

SJS Investment Consulting’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$14.4K	Sell	337 -140	-29%	-$7.6K	﹤0.01%	927
2026 Q1	$29.9K	Sell	477 -272	-36%	-$21.8K	﹤0.01%	551
2025 Q4	$71.4K	Buy	749 +577	+335%	+$56.6K	0.01%	255
2025 Q3	$16.8K	Buy	172 +2	+1%	+$207	﹤0.01%	555
2025 Q2	$18.3K	Sell	170 -66	-28%	-$6.68K	﹤0.01%	288
2025 Q1	$23.8K	Buy	236 +50	+27%	+$5.04K	﹤0.01%	267
2024 Q4	$16.6K	Sell	186 -12	-6%	-$1.06K	﹤0.01%	298
2024 Q3	$16.6K	Hold	198	–	–	﹤0.01%	309
2024 Q2	$15.2K	Hold	198	–	–	﹤0.01%	298
2024 Q1	$13.6K	Buy	198 +50	+34%	+$3.21K	﹤0.01%	321
2023 Q4	$8.56K	Sell	148 -2	-1%	-$107	﹤0.01%	308
2023 Q3	$7.92K	Hold	150	–	–	﹤0.01%	307
2023 Q2	$8.11K	Sell	150 -2	-1%	-$104	﹤0.01%	289
2023 Q1	$7.61K	Buy	152 +10	+7%	+$471	﹤0.01%	318
2022 Q4	$6.57K	Hold	142	–	–	﹤0.01%	323
2022 Q3	$6K	Buy	+142	New	+$5.7K	﹤0.01%	314
2022 Q1	$4K	Buy	106 +6	+6%	+$260	﹤0.01%	453
2021 Q4	$4K	Buy	+100	New	+$4.2K	﹤0.01%	438

Other funds holding BSX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

SJS Investment Consulting's BSX Position: Q2 2026 in Review

SJS Investment Consulting reduced its Boston Scientific (BSX) stake by 29% in Q2 2026, selling an estimated $7.6K and leaving 337 shares worth $14.4K. The position accounts for ﹤0.01% of the portfolio, ranked #927.

SJS Investment Consulting first reported a position in BSX in Q4 2021 and has held it in 18 quarters since. The position peaked at $71.4K in Q4 2025. 1,482 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

SJS Investment Consulting held 337 shares of Boston Scientific worth $14.4K as of Q2 2026.
SJS Investment Consulting sold 140 Boston Scientific shares in Q2 2026, an estimated $7.6K.
Boston Scientific made up ﹤0.01% of SJS Investment Consulting's portfolio in Q2 2026, its #927 holding.
SJS Investment Consulting first reported a position in Boston Scientific in Q4 2021 and has held it in 18 quarters since.
SJS Investment Consulting's Boston Scientific position peaked at $71.4K in Q4 2025.
1,482 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on SJS Investment Consulting's 13F filing for Q2 2026, filed 22 Jul 2026.